Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction
Status:
Completed
Trial end date:
2017-09-13
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess adherence and persistence to BETASERON
therapy in patients who are using the BETACONNECT auto-injector device (BETACONNECT device).
The secondary objective of this study is to assess patient-reported satisfaction with the
BETACONNECT device.